히알루론산 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Hyaluronic Acid Market size is expected to reach USD 12.08 Billion in 2034 from USD 6.29 Billion (2025) growing at a CAGR of 7.52% during 2026-2034.

The global hyaluronic acid market is experiencing steady growth due to its increasing use in cosmetics, pharmaceuticals, and medical treatments. Hyaluronic acid is widely used in skincare products for its excellent moisturizing and anti-aging properties. In the healthcare sector, it is commonly used in dermal fillers, osteoarthritis injections, and ophthalmic surgeries. Rising consumer awareness about skincare and aesthetic treatments has significantly contributed to the market's expansion across developed and emerging economies.

One of the key drivers of this market is the growing demand for minimally invasive cosmetic procedures. Dermal fillers containing hyaluronic acid are widely used for facial rejuvenation, wrinkle reduction, and lip enhancement. Additionally, the increasing prevalence of joint disorders such as osteoarthritis has boosted the demand for hyaluronic acid injections used in viscosupplementation therapies. The rapid expansion of the beauty and personal care industry is also playing an important role in driving market growth.

Looking ahead, the market is expected to witness strong growth as research and development activities continue to expand the application areas of hyaluronic acid. Innovations in biotechnology and fermentation-based production methods are improving product quality and reducing manufacturing costs. With increasing demand for advanced aesthetic treatments and regenerative medicine solutions, the hyaluronic acid market is projected to grow significantly in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Multiple Injection Dose
• Single Injection Dose

By Application

• Osteoarthritis
• Dermal Fillers
• Ophthalmic
• Vesicoureteral Reflux
• Other Applications

By Grade

• Pharmaceutical Grade Hyaluronic Acid
• Cosmetic Grade Hyaluronic Acid

By Source of Origin

• Non-avian Origin
• Avian Origin

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Clinics
• Other End Use

COMPANIES PROFILED

• Roche, Sanofi, LG Chem Ltd, Galderma, Ferring Pharmaceuticals, Allergan Aesthetics an AbbVie company, Seikagaku Corporation, Bioventus LLC, Anika Therapeutics Inc, Lifecore Biomedical, Bloomage Biotechnology Corporation Limited, Teleflex Incorporated Deflux brand, Kewpie Corporation, Altergon Italia Srl, Topscience Co Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HYALURONIC ACID MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Multiple Injection Dose Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Single Injection Dose Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HYALURONIC ACID MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Osteoarthritis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Dermal Fillers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Ophthalmic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Vesicoureteral Reflux Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HYALURONIC ACID MARKET: BY GRADE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Grade
• 6.2. Pharmaceutical Grade Hyaluronic Acid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cosmetic Grade Hyaluronic Acid Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HYALURONIC ACID MARKET: BY SOURCE OF ORIGIN 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Source Of Origin
• 7.2. Non-avian Origin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Avian Origin Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HYALURONIC ACID MARKET: BY END USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End Use
• 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Orthopedic Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Other End Use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL HYALURONIC ACID MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Application
  • 9.2.3 By Grade
  • 9.2.4 By Source Of Origin
  • 9.2.5 By End Use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Application
  • 9.3.3 By Grade
  • 9.3.4 By Source Of Origin
  • 9.3.5 By End Use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Application
  • 9.4.3 By Grade
  • 9.4.4 By Source Of Origin
  • 9.4.5 By End Use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Application
  • 9.5.3 By Grade
  • 9.5.4 By Source Of Origin
  • 9.5.5 By End Use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Application
  • 9.6.3 By Grade
  • 9.6.4 By Source Of Origin
  • 9.6.5 By End Use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL HYALURONIC ACID INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Roche
  • 11.2.2 Sanofi
  • 11.2.3 LG Chem Ltd
  • 11.2.4 Galderma
  • 11.2.5 Ferring Pharmaceuticals
  • 11.2.6 Allergan Aesthetics (an AbbVie Company)
  • 11.2.7 Seikagaku Corporation
  • 11.2.8 Bioventus LLC
  • 11.2.9 Anika Therapeutics Inc
  • 11.2.10 Lifecore Biomedical
  • 11.2.11 Bloomage Biotechnology Corporation Limited
  • 11.2.12 Teleflex Incorporated (Deflux Brand)
  • 11.2.13 Kewpie Corporation
  • 11.2.14 Altergon Italia S.r.l
  • 11.2.15 Topscience Co. Ltd